Futsikort - a drug with anti-inflammatory and antibacterial action.
By analogues Futsikorta
mode of action include Fucidinum, Prefuzin G.
Structure and Composition
The drug is available as a cream and used in dermatology. Each gram of cream Futsikort by instructions contained 1 mg of betamethasone valerate and fusidic acid 20 mg micronized. Accessories: chlorocresol, cetomacrogol, sodium dihydrogen phosphate, liquid paraffin, sodium hydroxide, tsetoasterilovy alcohol, soft white paraffin, purified water.
Pharmacological action Futsikorta
Futsikort - combined drug having antipruritic, anti-inflammatory action of betamethasone and antimicrobial effects of fusidic acid.
Futsikort inhibits the growth and proliferation of streptococci, staphylococci and mycobacteria. Resistance to the action Futsikorta Proteus spp., Salmonella spp, Escherichia coli, viruses, and fungal pathogens.
According to the instructions Futsikort Futsikorta and analogues are used in the following skin diseases:
- atopic dermatitis;
- atopic dermatitis;
- congestive eczema;
- contact dermatitis;
- seborrheic dermatitis;
- lupus erythematosus;
- limited neurodermatitis;
- nummular eczema.
Futsikort - Instructions for use
Futsikort can be used for applications on any parts of the body and the face (except eye, mucous membranes, and the wound surfaces of mammary glands during lactation). The cream should be applied to a thin layer to the affected areas two to three times a day for ten days.
- hypersensitivity to any component of the cream Futsikort;
- fungal and viral infections;
- open wounds;
- trophic ulcers;
- acne vulgaris;
- dermatological manifestations of syphilis;
- dermatological post-vaccination reactions.
Side effects Futsikorta
Judging by the reviews,
Futsikort often well tolerated. In rare cases, the drug causes an allergic reaction.
Reviews Futsikorte confirm that the prolonged use of the cream on large areas contributes to the formation of stretch marks and sometimes causes skin atrophy, hypopigmentation, a local hirsutism, systemic manifestations.
Since the drug is not teratogenic and embryotoxic action, it does not exclude the possibility of using cream to treat skin infections in pregnant women and in infants. However, do not exceed the period of therapy with this agent, as some reviews about Futsikorte confirm the fact that long-term use in the treatment of the cream promotes suppression of adrenal function and the development of symptoms of Cushing.
Futsikort stored in a dry place, protected from sunlight, at a temperature not exceeding 25 ° C. Shelf life - three years.